BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 146599)

  • 1. [Treatment of hypercalcaemic syndrome in tumour patients, especially with mithramycin].
    Senn HJ; Peyer P
    Dtsch Med Wochenschr; 1978 Jan; 103(3):101-7. PubMed ID: 146599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hypercalcemia syndrome with mithramycin].
    Gasser AB; Flury R; Senn HJ
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1792-4. PubMed ID: 4281933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monotherapy with clodronate for tumor-induced hypercalcemia].
    Harjung H; Fritze D
    Dtsch Med Wochenschr; 1990 Jan; 115(2):48-52. PubMed ID: 2136827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypercalcemia with mithramycin].
    Lemaire V; Kuntz D; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1975 Feb; 42(2):93-6. PubMed ID: 124091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypercalcemia using mithramycin].
    Saint-Hillier Y; Perol C; Dupond JL; Apffel F; Leconte des Floris RL
    J Urol Nephrol (Paris); 1975; 81(4-5):326-34. PubMed ID: 125801
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercalcemic crisis in neoplastic diseases: management with mithramycin.
    Elias EG; Evans JT
    Surgery; 1972 Apr; 71(4):631-5. PubMed ID: 4259864
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin.
    Fillastre JP; Maitrot J; Canonne MA; Gray H; Jeanne C; Bastit P; Bourgeois T
    Chemotherapy; 1974; 20(5):280-95. PubMed ID: 4278249
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mithramycin therapy of hypercalcemia in patients with neoplastic diseases].
    Skovgaard M
    Ugeskr Laeger; 1974 Aug; 136(32):1814-7. PubMed ID: 4277881
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
    Caro JF; Besarab A; Glennon JA
    Cancer Treat Rep; 1978 Oct; 62(10):1561-3. PubMed ID: 152145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
    Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mithramycin (mithracin).
    Med Lett Drugs Ther; 1973 Oct; 12(21):86-7. PubMed ID: 4270066
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypercalcemia with Mithramycin].
    Eisinger J; D'Omezon Y; Godde JL; Laponche AM; Recordier AM
    Mars Med; 1972; 109(4):267-73. PubMed ID: 4262719
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypercalcemia associated with neoplastic disease.
    Muggia FM; Heinemann HO
    Ann Intern Med; 1970 Aug; 73(2):281-90. PubMed ID: 5454265
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum calcium in bronchial carcinoma: a population-based study.
    Gislason T; Palmér M; Nõu E
    Eur J Respir Dis; 1987 Jan; 70(1):8-13. PubMed ID: 3817068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
    Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
    Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of thyrocalcitonin mithramycin, and indomethacin treatment of a case of hypercalcemia in tumor of the lung].
    Pesce L; Del Torre L; Busolin G; Macaluso S
    Arch Monaldi; 1977; 31(2):119-31. PubMed ID: 141246
    [No Abstract]   [Full Text] [Related]  

  • 17. Mithramycin for hypercalcemia of malignant disease.
    Godfrey TE
    Calif Med; 1971 Oct; 115(4):1-4. PubMed ID: 4255688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
    Rosol TJ; Capen CC
    J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mithramycin in the management of malignant hypercalcaemia.
    Nielsen J; Suthons S; Stevens FR
    Med J Aust; 1973 Dec; 2(24):1091-4. PubMed ID: 4272858
    [No Abstract]   [Full Text] [Related]  

  • 20. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.